2 Stocks Under $50 Worth Investigating and 1 We Ignore

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here are two stocks under $50 with massive upside potential and one that could be down big.

One Stock Under $50 to Sell:

Sally Beauty (SBH)

Share Price: $15.27

Catering to both everyday consumers as well as salon professionals, Sally Beauty (NYSE:SBH) is a retailer that sells salon-quality beauty products such as makeup and haircare products.

Why Do We Think SBH Will Underperform?

1. Absence of new stores indicates weak demand as management focuses on improving existing location performance
2. Weak same-store sales trends over the past two years suggest there may be few opportunities in its core markets to open new locations
3. Modest revenue base of $3.70 billion gives it less fixed cost leverage and fewer distribution channels than larger companies

At $15.27 per share, Sally Beauty trades at 7.3x forward P/E. Dive into our free research report to see why there are better opportunities than SBH.

Two Stocks Under $50 to Watch:

Astrana Health (ASTH)

Share Price: $23.83

Formerly known as Apollo Medical Holdings until early 2024, Astrana Health (NASDAQ:ASTH) operates a technology-powered healthcare platform that enables physicians to deliver coordinated care while successfully participating in value-based payment models.

Why Could ASTH Be a Winner?

1. Market share has increased this cycle as its 47.7% annual revenue growth over the last two years was exceptional
2. Market share will likely rise over the next 12 months as its expected revenue growth of 34.2% is robust
3. Earnings per share have comfortably outperformed the peer group average over the last five years, increasing by 11.6% annually

Astrana Health is trading at $23.83 per share, or 6.9x forward EV-to-EBITDA. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.

NerdWallet (NRDS)

Share Price: $14.36

Born from founder Tim Chen's frustration with the lack of transparent credit card information when helping his sister in 2009, NerdWallet (NASDAQ:NRDS) is a digital platform that provides financial guidance to help consumers and small businesses make smarter decisions about credit cards, loans, insurance, and other financial products.

Why Do We Like NRDS?

1. Annual revenue growth of 26.5% over the past five years was outstanding, reflecting market share gains this cycle
2. Additional sales over the last two years increased its profitability as the 266% annual growth in its earnings per share outpaced its revenue

NerdWallet’s stock price of $14.36 implies a valuation ratio of 10.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free for active Edge members.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.